# Equifax share price today (Equifax Inc., EFX)

> Equifax Inc.'s earnings have grown faster than its share price. Earnings per share grew +9.9% in a year while the price moved −11.1%. EFX · Industrials · Consulting Services · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/efx

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: $187.72 (−11.1% in a year)
- P/E: 30.4× (lower than 87% of the last 4.6 years)
- Revenue (Sep 2026): $1.7 B (+9.6% on a year ago)
- Profit (Sep 2026): $212 M (+32.1% on a year ago)
- Operating margin: 21.0% (+3.9 points on a year ago)
- ROE: 14%, FY25
- ROIC: 9.5%, against a 10.0% cost of capital: −0.5 points

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Equifax share price today? Equifax Inc.'s share price was $187.72 at the close on 3 November 2026. It has been stalling near its high for 3 weeks. That is 6.3% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 3 weeks in a row. In the last 52 weeks it traded between $140 and $227, and at that close it sat 55% of the way up from that low. Over the last 10 years the share price moved +42% while the S&P 500 moved +255%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Equifax pay? Equifax Inc. paid $2.18 per share over the last four reported quarters. The most recent declaration was $0.56 for Sep 2026. At today's price of $187.72 that is a yield of 1.16%, based on dividends already paid, not a forecast. ## Which stock lists is Equifax on? Equifax is on one of our US lists: S&P 500 companies. [S&P 500 companies](https://www.sectoralpha.in/sp-500-stocks)

## Is Equifax profitable? Equifax Inc. earned $212 M of net profit in the Sep 2026 quarter, +32.1% on the same quarter a year earlier. Full-year FY25 profit was $660 M. Over 4 years profit has grown −2.9% a year on average. That is 12.5% of the quarter's revenue. The same quarter a year earlier earned $160 M. For the full year, FY25 profit was $660 M (+9.3% on the year before). Why profit moved: revenue changed +9.6% on a year earlier and the margin moved +3.9 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +14.5% and revenue +10.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Equifax make, and is it growing? Equifax Inc. reported $1.7 B of revenue in the Sep 2026 quarter, +9.6% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 5.4% a year on average. The last full year, FY25, came in at $6.1 B. The last four reported quarters add to $6.6 B. FY25 revenue was $6.1 B, +6.9% on the year before. Recent pace: the last four quarters grew +10.9% on average, against 5.4% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +10.9%, against +8.6% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +12.8%, against +14.9% a year (stabilising). ## How much of every $100 of sales does Equifax keep? Equifax Inc.'s operating margin was 21.0% in the Sep 2026 quarter, 3.9 percentage points higher than the same quarter a year ago. Across 5 years it has been between 18.4% and 23.1%. The latest quarter is within that range. Why the margin moved: operating margin changed +3.9 percentage points on the year while gross margin changed −1.6 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Equifax's profit turning into cash? Over the last 3 years, 224% of Equifax Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $1.6 B of operating cash against $660 M of profit. After $481 M of spending on assets, $1.1 B was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Equifax's cash go? Equifax Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $1.6 B on assets over the last 3 years. Averaged over those years that is 8.7% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $1.6 B over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Equifax's P/E ratio, and how does it compare with its own history? Equifax Inc.'s P/E is 30.4×, near the low end of its own history: it has been lower only 13% of the time. Its usual P/E (the middle reading) is 43.6×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +9.9% while the price moved −11.1%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 3 years the price moved +1.1% a year; about +13.6% a year came from earnings growth and about −12.5 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Equifax business getting better or worse? Equifax Inc.'s business is giving mixed signals. Growth has been steadily positive, but ROCE at 12.0% is below the 15% level needed to call it steady growth. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Equifax earn on its capital? Equifax Inc. earned a ROE of 14% in FY25. That is up from a low of 12% in FY23. Its return on capital used (ROIC) is 0.5 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 10.9% net margin and 0.51× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 10.9% net margin × 0.51× asset turnover × 2.50× leverage (assets divided by equity) ≈ 13.9% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 9.5% − 10.0% = −0.5 percentage points. The 10.0% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Equifax have too much debt? Equifax Inc. has total debt of $5.2 B against shareholder equity of $4.6 B as of Sep 2026, so its debt is 1.13× its equity. Year by year, that ratio went from 1.47 in FY21 to 1.11 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Equifax shareholding pattern? 4.8% of Equifax Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.9 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Equifax from balance-sheet trouble? For Equifax Inc., the Z-score is 3.59. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 3.59 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Equifax rank in its industry? 52.8 out of 100, rank 5 of 13 in Consulting Services, with 85% of the evidence available. Equifax Inc. scores 52.8 out of 100 against the 13 companies it is compared with in Consulting Services, ranking 5. Earnings are strong; relative strength in its sector is -17.3% and the one-year return is -9.6%. The four parts add up to the total exactly: 25.8 + 13.7 + 9.5 + 3.8 = 52.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Equifax compared with? Equifax ranks 5 of 13 Consulting Services companies on the 4-Factor Sector Score, with 52.8 out of 100. 1. [Huron Consulting Group Inc.](https://www.sectoralpha.in/us/stocks/hurn) HURN · leader · Most evidence points up · 81% evidence 73.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.3/35 · Revenue 13.9% · Profit 9.5% · Operating margin change 0.2 points · 83% evidence Capital efficiency 15.3/25 · ROCE 16.1% · Operating margin 11.7% · 76% evidence Valuation 14.2/20 · P/E 11.9× · PEG 0.71 · 65% evidence Relative strength 19.5/20 · Lead over its industry 11.7% · Lead over S&P 500 29.3% · 1 year 19.6% · 100% evidence · 12 of 12 weeks ahead Exact sum: 24.3 + 15.3 + 14.2 + 19.5 = 73.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [SBC Medical Group Holdings Incorporated](https://www.sectoralpha.in/us/stocks/sbc) SBC · leader · Most evidence points up · 81% evidence 72.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.1/35 · Revenue -6.4% · Profit 44.1% · Operating margin change 4.9 points · 83% evidence Capital efficiency 17.4/25 · ROCE 19.9% · Operating margin 38.5% · 76% evidence Valuation 16.2/20 · P/E 6.4× · PEG 0.14 · 65% evidence Relative strength 18.9/20 · Lead over its industry 8.3% · Lead over S&P 500 25.4% · 1 year 65.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.1 + 17.4 + 16.2 + 18.9 = 72.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [FTI Consulting, Inc.](https://www.sectoralpha.in/us/stocks/fcn) FCN · turning · Evidence leans up · 81% evidence 55.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 7.1% · Profit 1.6% · Operating margin change -1.3 points · 83% evidence Capital efficiency 13.4/25 · ROCE 14% · Operating margin 9.2% · 76% evidence Valuation 11.8/20 · P/E 17.4× · PEG 1.06 · 65% evidence Relative strength 13.1/20 · Lead over its industry -3.1% · Lead over S&P 500 12.8% · 1 year 18.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 17.3 + 13.4 + 11.8 + 13.1 = 55.6 · What this means: Relative strength against the index is 12.8%, and revenue and profit growth are weak. 4. [Verisk Analytics, Inc.](https://www.sectoralpha.in/us/stocks/vrsk) VRSK · turning · Too little evidence to rank firmly · 56% evidence 54.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue n/a · Profit n/a · Operating margin change -0.8 points · 39% evidence Capital efficiency 20.8/25 · ROCE 41.7% · Operating margin 45.1% · 76% evidence Valuation 8.5/20 · P/E 26.6× · PEG n/a · 15% evidence Relative strength 4.5/20 · Lead over its industry -16.8% · Lead over S&P 500 -3.1% · 1 year -8.2% · 100% evidence · 3 of 12 weeks ahead Exact sum: 21.1 + 20.8 + 8.5 + 4.5 = 54.9 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. Equifax Inc. this page EFX · turning · Evidence leans up · 85% evidence 52.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.8/35 · Revenue 10.9% · Profit 13.1% · Operating margin change 3.9 points · 95% evidence Capital efficiency 13.7/25 · ROCE 11.6% · Operating margin 21% · 76% evidence Valuation 9.5/20 · P/E 21.7× · PEG 1.27 · 65% evidence Relative strength 3.8/20 · Lead over its industry -17.3% · Lead over S&P 500 -3.6% · 1 year -9.6% · 100% evidence · 4 of 12 weeks ahead Exact sum: 25.8 + 13.7 + 9.5 + 3.8 = 52.8 · What this means: Earnings are strong; relative strength in its sector is -17.3% and the one-year return is -9.6%. 6. [CRA International, Inc.](https://www.sectoralpha.in/us/stocks/crai) CRAI · breaking out · Evidence leans up · 85% evidence 52.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 8.8% · Profit -12.5% · Operating margin change 1.9 points · 95% evidence Capital efficiency 18.5/25 · ROCE 30.2% · Operating margin 11.2% · 76% evidence Valuation 4.2/20 · P/E 19.3× · PEG 3.24 · 65% evidence Relative strength 9.2/20 · Lead over its industry -6.9% · Lead over S&P 500 8.1% · 1 year 8.3% · 100% evidence · 10 of 12 weeks ahead Exact sum: 20.3 + 18.5 + 4.2 + 9.2 = 52.2 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 7. [Booz Allen Hamilton Holding Corporation](https://www.sectoralpha.in/us/stocks/bah) BAH · breaking out · Evidence leans down · 85% evidence 48.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.9/35 · Revenue -6.2% · Profit -5.4% · Operating margin change -1 points · 95% evidence Capital efficiency 14.2/25 · ROCE 16.6% · Operating margin 8.8% · 76% evidence Valuation 15.2/20 · P/E 10.7× · PEG 0.24 · 65% evidence Relative strength 8.5/20 · Lead over its industry -10.3% · Lead over S&P 500 4.4% · 1 year -0.5% · 100% evidence · 7 of 12 weeks ahead Exact sum: 10.9 + 14.2 + 15.2 + 8.5 = 48.8 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [ICF International, Inc.](https://www.sectoralpha.in/us/stocks/icfi) ICFI · leader · Evidence leans down · 81% evidence 44.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.3/35 · Revenue -7.9% · Profit -18.4% · Operating margin change 0 points · 83% evidence Capital efficiency 10.0/25 · ROCE 8.4% · Operating margin 8.4% · 76% evidence Valuation 9.7/20 · P/E 14.9× · PEG 1.42 · 65% evidence Relative strength 12.1/20 · Lead over its industry -0.3% · Lead over S&P 500 15.7% · 1 year 19.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 12.3 + 10 + 9.7 + 12.1 = 44.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Forrester Research, Inc.](https://www.sectoralpha.in/us/stocks/forr) FORR · losing its lead · Most evidence points down · 64% evidence 34.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.1/35 · Revenue -8% · Profit n/a · Operating margin change -1.2 points · 62% evidence Capital efficiency 5.8/25 · ROCE 1.8% · Operating margin 5.5% · 76% evidence Valuation 11.5/20 · P/E -3.8× · PEG n/a · 15% evidence Relative strength 6.4/20 · Lead over its industry -4.6% · Lead over S&P 500 9.8% · 1 year 27.3% · 100% evidence · 10 of 12 weeks ahead Exact sum: 11.1 + 5.8 + 11.5 + 6.4 = 34.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. Zi Yun Dong Fang Limited YLY · Too little evidence to rank firmly · 11% evidence 57.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/43.75 · Revenue n/a · Profit n/a · Operating margin change n/a · 0% evidence Capital efficiency 22.8/31.25 · ROCE 110.6% · Operating margin n/a · 46% evidence Valuation 12.5/25 · P/E n/a · PEG n/a · 0% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 21.9 + 22.8 + 12.5 = 57.2 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 11. [Etoiles Capital Group Co., Ltd](https://www.sectoralpha.in/us/stocks/efty) EFTY · Too little evidence to rank firmly · 19% evidence 39.9 out of 100 Growth Capital Valuation Relative
12. Enigmatig Limited EGG · Too little evidence to rank firmly · 19% evidence 38.1 out of 100 Growth Capital Valuation Relative
13. Resources Connection, Inc. RGP · Too little evidence to rank firmly · 47% evidence 27.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Consulting Services](https://www.sectoralpha.in/us/sectors/consulting-services), all 13 compared on one page. ## Which companies are close to Equifax in size? Equifax is the 2nd largest of 11 Consulting Services companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Verisk Analytics, Inc. Just below it: Booz Allen Hamilton Holding Corporation, FTI Consulting, Inc., Huron Consulting Group Inc., ICF International, Inc. and CRA International, Inc. ### Consulting Services companies close in size

1. [Verisk Analytics, Inc.](https://www.sectoralpha.in/us/stocks/vrsk) $25.6 billion
2. Equifax Inc. $22 billion
3. [Booz Allen Hamilton Holding Corporation](https://www.sectoralpha.in/us/stocks/bah) $10.3 billion
4. [FTI Consulting, Inc.](https://www.sectoralpha.in/us/stocks/fcn) $5.2 billion
5. [Huron Consulting Group Inc.](https://www.sectoralpha.in/us/stocks/hurn) $3 billion
6. [ICF International, Inc.](https://www.sectoralpha.in/us/stocks/icfi) $1.8 billion
7. [CRA International, Inc.](https://www.sectoralpha.in/us/stocks/crai) $1.2 billion

[All 11 Consulting Services companies, largest first](https://www.sectoralpha.in/us/sectors/consulting-services#all-companies)

### Companies close in size in other industries

1. [Amcor plc](https://www.sectoralpha.in/us/stocks/amcr) $22.6 billion · Packaging & Containers
2. [T. Rowe Price Group, Inc.](https://www.sectoralpha.in/us/stocks/trow) $22.6 billion · Asset Management
3. Equifax Inc. $22.5 billion
4. [Symbotic Inc.](https://www.sectoralpha.in/us/stocks/sym) $22.5 billion · Specialty Industrial Machinery
5. [KeyCorp](https://www.sectoralpha.in/us/stocks/key) $22.3 billion · Banks - Regional

## What else do people ask about Equifax? ### What is Equifax's stock price today? Equifax Inc.'s stock price is $187.72, −11.1% over the past year. The whole company is worth $22.0 B on the market. In the last 52 weeks it traded between $140 to $227; today it is 55% of the way up from the low, 6.3% above its 200-day average (as of 3 November 2026). ### What were Equifax's latest quarterly results? Equifax Inc. reported revenue of $1.7 B and net profit of $212 M for the Sep 2026 quarter. Revenue rose 9.6% and profit rose 32.1% compared with a year earlier. Earnings per share were $1.79. The operating margin was 21.0%, 3.9 percentage points higher than a year earlier (as of 3 November 2026). ### What is Equifax's market cap? Equifax Inc.'s market capitalisation is $22.0 B at a stock price of $187.72. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Equifax performing? Equifax Inc.'s share price has been stalling near its high for 3 weeks. In its latest quarter, revenue rose 9.6% and profit rose 32.1% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 3 weeks running (as of 3 November 2026). ### Will Equifax's stock price go up? This page does not forecast Equifax Inc.'s stock price. What it shows instead: the stock price is $187.72, and it has been stalling near its high for 3 weeks. Its P/E of 30.4× is higher than 13% of its own last 5 years (as of 3 November 2026). ### Where is Equifax in its business cycle? Equifax Inc.'s FY25 operating margin was 18.8%, against a 5-year range of 18.4% to 23.1%: the low end of its own range, which is often where recoveries start. The latest quarter was 21.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Equifax story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Equifax a stock worth studying right now? What the numbers show: Equifax Inc.'s earnings have grown faster than its share price. Earnings per share grew +9.9% in a year while the price moved −11.1%. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- S&P 500 companies: https://www.sectoralpha.in/sp-500-stocks

This is research, not advice. We’re not SEBI-registered.